2022 Endocrine Case Management: Meet the Professor
Image For Activity Cover
Availability
On-Demand
Cost
Member: $59.00
Non-Member: $79.00
In-Training Member: $39.00
Resident Member: $59.00
Resident Non-Member: $79.00
Credit Offered
30 AMA PRA Category 1 Credits
30 Participation Credits
  • Course Description
  • Target Audience
  • Learning Objectives
  • Accreditation Statement
  • Faculty and Disclosures
  • Recommended

Endocrine Case Management: Meet the Professor is designed to provide physicians with a concise and high-quality review of more than 35 common and rare endocrine disorders to help you keep your practice current. It consists of case-based clinical vignettes and rationales by experts in all areas of endocrinology, diabetes, and metabolism.

Endocrine Case Management: Meet the Professor provides case-based education to clinicians interested in improving patient care.  

Endocrine Case Management: Meet the Professor will allow learners to assess their knowledge of all aspects of endocrinology, diabetes, and metabolism. 

Upon completion of this educational activity, learners will be able to: 

  • Recognize clinical manifestations of endocrine and metabolic disorders and select among current options for diagnosis, management, and therapy. 
  • Identify risk factors for endocrine and metabolic disorders and develop strategies for prevention. 
  • Evaluate endocrine and metabolic manifestations of systemic disorders. 
  • Use existing resources pertaining to clinical guidelines and treatment recommendations for endocrine and related metabolic disorders to guide diagnosis and treatment. 
Logo, company nameDescription automatically generated

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has received Accreditation with Commendation. 

The Endocrine Society designates this enduring material for a maximum of 30.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

2022 Endocrine Case Management: Meet the Professor Faculty

Bradley Anawalt, MD
University of Washington

Wiebke Arlt, MD, DSc, FRCP, FMedSci
University of Birmingham

Ambika Ashraf, MD
Children's Hospital/University of Alabama at Birmingham

Annika M. A. Berends, MD
University Medical Center Groningen

Nienke Biermasz, MD
Leiden University Medical Center

Maria Brandi, MD, PhD
FIRMO Foundation

Sue Brown, MD
University of Virginia 

Jonathan Campbell, PhD
Duke University

Uriel Clemente-Gutierrez, MD
University of Texas MD Anderson Cancer Center

Marc-Andre Cornier, MD
Medical University of South Carolina

Ricardo Correa, MD, EdD
University of Arizona College of Medicine Phoenix

Melanie Cree-Green, MD, PhD
University of Colorado and Children’s Hospital Colorado

David D'Alessio, MD
Duke University School of Medicine

Caroline Davidge-Pitts, MD, MBBCH
Mayo Clinic

Diva Del Carmen De Leon-Crutchlow, MD, MSCE
Children's Hospital of Philadelphia

Ilene Fennoy, MD, MPH
Columbia University

Maria Fleseriu, MD
Oregon Health & Science University

Rachel Gafni, MD
NIH

Benjamin Gigliotti, MD 
University of Rochester School of Medicine & Dentistry

Mark Gurnell, MD, PhD
University of Cambridge, Wellcome Trust-MRC Institute of Metabolic Science & School of Clinical Medicine

Bryan Haugen, MD
University of Colorado Denver Medical Campus

Kathleen Hoeger, MD, MPH
University of Rochester

Bernice L. Huang, MD
University of Texas MD Anderson Cancer Center

Sean Iwamoto, MD
University of Colorado School of Medicine & Rocky Mountain Regional VA Medical Center

Channa Jayasena, MD
Imperial College London

Michiel Kerstens, MD, PhD
University Medical Center Groningen

Julia Kharlip, MD
University of Pennsylvania

Bente Langdahl, MD, PhD, DMSc
Aarhus University Hospital

Lawrence Clarke Layman, BS, MD
Medical College of Georgia at Augusta University

Mike Lewiecki, MD
New Mexico Clinical Research & Osteoporosis Center

Sarah Mayson, MD
University of Colorado School of Medicine

Elizabeth McAninch, MD
Stanford University School of Medicine

Manpreet Mundi, MD
Mayo Clinic

Connie Baum Newman, MD, MACP
New York University School of Medicine

Rocio Pereira, MD
Denver Health Medical Center

Nancy Perrier, MD
University of Texas MD Anderson Cancer Center

Alessandro Prete, MD
University of Birmingham

Martin Reincke, MD
Medizinische Klinik und Poliklinik IV

Jane Reusch, MD
Rocky Mountain Regional VA Medical Center

Micol Rothman, MD
University of Colorado School of Medicine

David Saxon, MD
University of Colorado & Rocky Mountain Regional VA Medical Center

Ismat Shafiq, MD
University of Rochester

Ashley Shoemaker, MD
Vanderbilt University Medical Center

Jennifer Sipos, MD
Ohio State University

Savitha Subramanian, MD
University of Washington

Adina Turcu, MD, MS
University of Michigan

Varsha Vimalananda, MD, MPH
Center for Healthcare Organization and Implementation Research

Danica M. Vodopivec, MD
University of Texas MD Anderson Cancer Center

Maria Vogiatzi, MD
Children's Hospital of Philadelphia

Philip Zeitler, MD, PhD
Children's Hospital Colorado/University of Colorado

 

Annual Meeting Steering Committee (AMSC)

 

Stephen Hammes, PhD, MD – AMSC Chair
University of Rochester

Bulent O. Yildiz, MD, PhD – Clinical Practice Chair
Hacettepe University School of Medicine

Lauren Fishbein, MD, PhD – Clinical Science Chair
University of Colorado School of Medicine

 

Annual Meeting Steering Committee Clinical Peer Reviewers

Andrew Bauer, MD; Ernesto Bernal-Mizrachi, MD; Antonio Bianco, MD, PhD; Kristien Boelaert, MD, PhD; Massimiliano Caprio, MD, PhD; Bart Clarke, MD; Dawn Davis, MD, PhD; Daniel Dumesic, MD; Stephanie Fish, MD; Lauren Fishbein, MD, PhD; Matthew Freeby, MD; Adda Grimberg, MD; Niki Karavitaki, FRCP, PhD; Marta Korbonits, MD, PhD; Maria Veronica Mericq, MD; Gabrielle Page-Wilson, MD; Robin Peeters, MD, PhD; Margareta Pisarska, MD; Philipp Scherer, PhD; Jennifer Sherr, MD, PhD; Robert Wermers, MD; Selma Witchel, MD; Bulent O. Yildiz, MD; and Maria-Christina Zennaro, MD, PhD

STATEMENT OF INDEPENDENCE 

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s Annual Meeting Steering Committee.  

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Sue Brown, MD, Grant Recipient: Dexcom, Tandem Diabetes Care, Insulet Corporation

Jonathan Campbell, PhD, Advisory Board Member: ShouTi; Grant Recipient: Eli Lilly & Company, Novo Nordisk, Proteostasis; Speaker: Eli Lilly & Company

Marc-Andre Cornier, MD, Advisory Board Member: Regeneron Pharmaceuticals; Grant Recipient: Novartis Pharmaceuticals

David D'Alessio, MD, Advisory Board Member: Eli Lilly & Company; Grant Recipient: Merck & Co., Applied Therapeutics, Inc., Boehringer Ingelheim, Eli Lilly & Company, Genentech, Inc., Hanmi, Janssen Research & Development Company, Metacrine, Novartis Pharmaceuticals, Novo Nordisk, Oramed, Pfizer, Inc., REMD Biotherapeutics Inc., Sanofi, VTV Therapeutics. Research Investigator

Diva Del Carmen De Leon-Crutchlow, MD, MSCE, Consulting Fee: Ultragenyx, Zealand Pharma, Hanmi Pharmaceuticals, Heptares Therapeutics, Eiger Pharma, Crinetics Pharmaceuticals; Grant Recipient: Twist Pharma, Crinetics Pharmaceuticals; Stock Owner: Merck & Co.

Maria Fleseriu, MD, Consulting Fee: Ionis Pharmaceuticals Inc., Ipsen, Pfizer Global R&D, Crinetics, Amryt, Recordati; Grant Recipient: Ionis Pharmaceuticals Inc., Crinetics, Recordati

Channa Jayasena, MD, Grant Recipient: Logixx Pharma Ltd

Bente Langdahl, MD, PhD, DMSc, Advisory Board Member: Amgen, UCB, Gedeon-Richter; Grant Recipient: Novo Nordisk, Amgen; Speaker: Amgen, UCB, Gedeon-Richter, Astra-Zenica, Astellas

Mike Lewiecki, MD, Consulting Fee: Amgen Inc; Speaker: Amgen Inc

Elizabeth McAninch, MD, Owner/Co-Owner: Equilibrate Therapeutics

Ashley Shoemaker, MD, Advisory Board Member: Radius Health Inc, Saniona, Rhythm Pharmaceuticals

Savitha Subramanian, MD, Advisory Board Member: Abbott Laboratories, Akcea Therapeutics, Amarin

Adina Turcu, MD, MS, Advisory Board Member: Novartis; Consulting Fee: CinCor, PhaseBio

Philip Zeitler, MD, PhD, Consulting Fee: Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly & Company, Janssen Research & Development Company, Merck

The following faculty reported no relevant financial relationships:

Bradley Anawalt, MD; Wiebke Arlt, MD, DSc, FRCP, FMedSci; Ambika Ashraf, MD; Annika M. A. Berends, MD; Nienke Biermasz, MD; Maria Brandi, MD, PhD; Uriel Clemente-Gutierrez, MD;

Ricardo Correa, MD, EdD; Melanie Cree-Green, MD, PhD; Caroline Davidge-Pitts, MD, MBBCH; Ilene Fennoy, MD, MPH; Rachel Gafni, MD; Benjamin Gigliotti, MD; Mark Gurnell, MD, PhD; Bryan Haugen, MD; Kathleen Hoeger, MD, MPH; Bernice L. Huang, MD; Sean Iwamoto, MD; Michiel Kerstens, MD, PhD; Julia Kharlip, MD; Lawrence Clarke Layman, BS, MD; Sarah Mayson, MD; Manpreet Mundi, MD; Connie Baum Newman, MD, MACP; Rocio Pereira, MD; Nancy Perrier, MD; Alessandro Prete, MD; Martin Reincke, MD; Jane Reusch, MD; Micol Rothman, MD; David Saxon, MD; Ismat Shafiq, MD; Jennifer Sipos, MD; Varsha Vimalananda, MD, MPH; Danica M. Vodopivec, MD; and Maria Vogiatzi, MD

The following AMSC peer reviewers reported relevant financial relationships:

Andrew Bauer, MD, Speaker: Hexal, AG

Antonio Bianco, MD, PhD, Consulting Fee: Allergan, BLA Technology, IBSA Foudnation, Synthonics

Kristien Boelaert, MD, PhD, Advisory Board: Pfizer, EISAI

Massimiliano Caprio, MD, PhD, Grant Recipient: Bayer AG

Bart Clarke, MD, Advisory Board: Bristol-Myers Squibb; Consulting Fee: Shire/Takeda, Inc., Calcilytix, Inc., Amolyt, Inc.

Dawn Davis, MD, PhD, Employee: Department of Veterans Affairs; Grant Recipient: Department of Veterans Affairs, NIH

Daniel Dumesic, MD, Advisory Board: Spruce BioSciences Inc.; Grant Recipient: NIH

Lauren Fishbein, MD, PhD, Advisory Board: PheoPara Alliance; Consulting Fee: Lantheus/Azedra

Matthew Freeby, MD, Grant Recipient: Novo Nordisk, Abbott Diabetes

Adda Grimberg, MD, Advisory Board: Pfizer; Consulting Fee: Sandoz; Grant Recipient: Eunice Kennedy Shriver National Institute of Child Health and Human Development

Niki Karavitaki, FRCP, PhD, Advisory Board: Recordati Rare Diseases, Pfizer, Ipsen; Speaker: HRA Pharma, Pfizer, Ipsen

Marta Korbonits, MD, PhD, Consultant Fee: ONO, Novo Nordisk, Corcept; Speaker: Pfizer, Ipsen

Maria Veronica Mericq, MD, Advisory Board: Pfizer, Sandoz, Merck, Novo Nordisk; Consultant Fee: Novartis/Sandoz; Grant Recipient: Merck

Gabrielle Page-Wilson, MD, Advisory Board: Strongbridge Biopharma, Recordati Rare Diseases, Inc.

Robin Peeters, MD, PhD, Advisory Board: Sanofi Genzyme, Bayer; Speaker: Berlin-Chemie, Goodlife Fertility BV, Institut Biochimique SA (IBSA), Sanofi Genzyme, Bayer, EISAI

Jennifer Sherr, MD, PhD, Advisory Board: Bigfoot Biomedical, Lilly, Insulet, Cecelia Health; Consultant Fee: Medtronic Diabetes, Sanofi; Grant Recipient: JDRF

The following AMSC peer reviewers reported no relevant financial relationships:

Ernesto Bernal-Mizrachi, MD; Stephanie Fish, MD; Margareta Pisarska, MD; Philipp Scherer, PhD; Robert Wermers, MD; Selma Witchel, MD; Bulent O. Yildiz, MD, PhD; and Maria-Christina Zennaro, MD, PhD

   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By